Your session is about to expire
← Back to Search
mHealth Texting Tool for Type 2 Diabetes
Study Summary
This trial will test a new mobile platform, MJS DIABETES, which uses text-messaging to capture patients' self-reported PROs in real-time. The platform will be integrated into the EHR system, the primary care practice and the lives of patients with T2D. A randomized control trial will be used to identify the efficacy of MJS DIABETES versus Usual Care (UC) on reduction HbA1c at 12-months, among 282 patients with T2D who receive care in safety-net practices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had type 2 diabetes for over 6 months, my HbA1c level is above 7%, and I am okay with texting in English or Spanish.I have had type 2 diabetes for over 6 months, my HbA1c level is above 7%, I speak English or Spanish, and I am okay with texting.I am a full-time primary care provider at a participating FHC and treat at least 5 patients with type 2 diabetes.
- Group 1: MJS DIABETES
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation recruiting senior citizens?
"According to the inclusivity conditions, individuals between 18 and 90 years of age can participate. In comparison, there exist 184 trials for minors and 897 clinical studies available for seniors."
To whom is this experimental procedure available?
"This clinical trial requires 346 participants with type 2 diabetes who are aged 18 to 90. The key criteria for applicants include: being a full-time primary care provider, providing medical services to at least 5 patients diagnosed with Type 2 Diabetes (T2D), having had the diagnosis of T2D for 6 months or more, displaying an HbA1c level greater than 7% in their Electronic Health Record on two separate occasions within a year, fluency in either English or Spanish and lastly agreement to send/receive text messages."
Are there any open slots available for participants in this experiment?
"Affirmative, records from clinicaltrials.gov show that this experiment is actively seeking new participants and has been since it was initially published on December 18th 2018. Of the 346 desired patients, they will all be recruited from a single location."
How many test subjects are included in this medical experiment?
"Affirmative, the information available on clinicaltrials.gov shows that this medical trial is currently recruiting individuals for participation. It was originally posted on December 18th 2018 and has since been updated as recently as August 25th 2022. 346 participants must be recruited from a single site."
Share this study with friends
Copy Link
Messenger